CFWAX
Price
$31.01
Change
+$0.26 (+0.85%)
Updated
Jul 10 closing price
Net Assets
564.65M
FMFTX
Price
$96.04
Change
+$0.91 (+0.96%)
Updated
Jul 10 closing price
Net Assets
784.75M
Interact to see
Advertisement

CFWAX vs FMFTX

CFWAX vs FMFTX Comparison Chart in %
View a ticker or compare two or three
VS
CFWAX vs. FMFTX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFWAX is a Hold and FMFTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FMFTX has more cash in the bank: 785M vs. CFWAX (565M). CFWAX (0.92) and FMFTX (0.88) have matching dividends . CFWAX was incepted earlier than FMFTX: CFWAX (18 years) vs FMFTX (20 years). CFWAX (1.29) and FMFTX (1.24) have similar cost to investors . FMFTX is a more actively managed with annual turnover of: 56.00 vs. CFWAX (24.00). CFWAX initial investment is less costly to investors than FMFTX (4%) vs FMFTX (4%). FMFTX has a lower initial minimum investment than CFWAX: FMFTX (250) vs CFWAX (1000). FMFTX annual gain was more profitable for investors over the last year : 8.00 vs. CFWAX (5.44). CFWAX return over 5 years is better than : 13.95 vs. FMFTX (3.96).
CFWAXFMFTXCFWAX / FMFTX
Total Expense Ratio1.241.24100%
Annual Report Gross Expense Ratio1.291.24104%
Fund Existence18 years20 years-
Gain YTD6.3087.16688%
Front Load5%4%150%
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets565M785M72%
Annual Yield % from dividends0.920.88105%
Returns for 1 year5.448.0068%
Returns for 3 years16.471.71962%
Returns for 5 years13.953.96352%
Returns for 10 years94.0438.50244%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELV425.178.94
+2.15%
Elevance Health
RGCO24.510.39
+1.62%
RGC Resources
IRMD97.690.49
+0.50%
iRadimed Corp
VIRT64.67-1.13
-1.72%
Virtu Financial Inc
MDCX0.37-0.04
-8.68%
Medicus Pharma Ltd